跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Defnac - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Defnac
Approved
STANDARD
Defnac
The Searle Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
73268037ef42d5ba
Company
The Searle Company Limited
Type
Standard
Approval Details
Approval Id
73268037ef42d5ba
Drug Approval Philippines Name
Defnac
Product Name
Defnac
Registration Number
DR-XY40922
Brand Name
Defnac
Generic Name
Diclofenac Sodium
Dosage Form
Solution For Injection
Dosage Strength
25 mg/mL
Manufacturer
The Searle Company Limited
Importer
Ambica International Correction
Distributor
Ambica International Correction
Company Detail Path
/organization/the-searle-company-limited
Issuance Date
31 May 2024
Expiry Date
15 June 2030
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
73268037ef42d5ba
Type
Standard
Back to Philippines FDA Approvals